Home › Castration-Resistant Prostatic Cancer › South Carolina
Castration-Resistant Prostatic Cancer clinical trials in South Carolina
4 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in South Carolina.
Cities in South Carolina
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Ralph H Johnson Veterans Hospital, Charleston
- Gibbs Cancer Center and Research Institute Pelham, Greer
- Carolina Urologic Research Center, Myrtle Beach
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07164443A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.